[ad_1] GlaxoSmithKline plc (NYSE: GSK) was awarded an average rating of "Hold" from the seventeen research companies that cover the stock, Marketbeat reports. Three badysts have rated the stock with a sales …
Read More »GlaxoSmithKline plc (GSK) Receives Analysts' "Hold" Consensus Rating
